Cargando…
Melatonin as a potential anticarcinogen for non-small-cell lung cancer
Non-small-cell lung cancer (NSCLC) is a leading cause of death from cancer worldwide. Melatonin, an indoleamine discovered in the pineal gland, exerts pleiotropic anticancer effects against a variety of cancer types. In particular, melatonin may be an important anticancer drug in the treatment of NS...
Autores principales: | Ma, Zhiqiang, Yang, Yang, Fan, Chongxi, Han, Jing, Wang, Dongjin, Di, Shouyin, Hu, Wei, Liu, Dong, Li, Xiaofei, Reiter, Russel J., Yan, Xiaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216835/ https://www.ncbi.nlm.nih.gov/pubmed/27102150 http://dx.doi.org/10.18632/oncotarget.8776 |
Ejemplares similares
-
Utilizing Melatonin to Alleviate Side Effects of Chemotherapy: A Potentially Good Partner for Treating Cancer with Ageing
por: Ma, Zhiqiang, et al.
Publicado: (2020) -
Pterostilbene exerts anticancer activity on non-small-cell lung cancer via activating endoplasmic reticulum stress
por: Ma, Zhiqiang, et al.
Publicado: (2017) -
PERK/eIF-2α/CHOP Pathway Dependent ROS Generation Mediates Butein-induced Non-small-cell Lung Cancer Apoptosis and G2/M Phase Arrest
por: Di, Shouyin, et al.
Publicado: (2019) -
The Protective Effects of Melatonin Against LPS-Induced Septic Myocardial Injury: A Potential Role of AMPK-Mediated Autophagy
por: Di, Shouyin, et al.
Publicado: (2020) -
Anticarcinogenic potentials of tea catechins
por: Li, Xiao-Xiang, et al.
Publicado: (2022)